Moreover, IL-6 could facilitate the progression of pancreatic cancer, while specific inhibitor of IL-6 trans-signaling by the gp130Fc protein could depress tumor growth and further decreased the microvessel density, reduced the number of distant metastases [60]. This evidence concerns the gene IL6 and pancreatic neoplasm.